GGrantIndex
Sort

11,323 grants matching glioblastoma

Glioma immunotherapy with strategies based on autonomous parvovirus MVMp

$117,418
Justin Cobb Paglino · Yale University · K08 · FY2014 · CA

Therapeutic Targeting of Receptor Tyrosine Kinase Hierarchies in Schwann Cell Neoplasms - Supplement for Diversity

$117,327
Steven L Carroll · Medical University Of South Carolina · R01 · FY2022 · NS

Therapeutic Targeting of Receptor Tyrosine Kinase Hierarchies in Schwann Cell Neoplasms

$117,327
Steven L Carroll · Medical University Of South Carolina · R01 · FY2023 · NS

Convection-Enhanced Thermo-chemotherapy Catheter System (CETCS)

$117,216
Christopher G Rylander · Wake Forest University Health Sciences · P01 · FY2021 · CA

Multivalent Inhibition of Integrin alphaVbeta3

$116,976
Stewart Durell · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA

Quantitative Analysis of GBM Invasion Mechanisms with New Imaging Protocol

$116,888
Jun Kong · Emory University · K25 · FY2014 · CA

Clinical Core

$116,845
Mark R. Gilbert · University Of Tx Md Anderson Can Ctr · P50 · FY2014 · CA

B7H1 Mediated Immunosuppression in Glioma

$116,763
Orin Bloch · Northwestern University At Chicago · R01 · FY2018 · CA

Clinical Core

$116,630
Mark R. Gilbert · University Of Tx Md Anderson Can Ctr · P50 · FY2016 · CA

Development of Mouse Astrocytoma Model for Preclinical Testing

$116,387
Karlyne M Reilly · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Genetics and Biology of Malignant Glioma

$116,344
Ronald Anthony Depinho · Dana-Farber Cancer Inst · P01 · FY2010 · CA

Administrative Core

$116,136
James R. Heath · California Institute Of Technology · U54 · FY2010 · CA

Role of myeloid-derived suppressor cells in local and systemic immunosuppression in glioblastoma

$116,034
Defne Bayik Watson · University Of Miami School Of Medicine · R00 · FY2024 · CA

Characterization of GEFT AS a Novel Glioblastoma Oncogene

$115,566
Milan Girish Chheda · Sloan-Kettering Inst Can Research · K08 · FY2009 · NS

Fibrin-CAR-T cells therapies to enhance efficacy in glioblastoma treatments

$115,503
Edikan Ogunnaike · Univ Of North Carolina Chapel Hill · K99 · FY2022 · NS

Fibrin-CAR-T cells therapies to enhance efficacy in glioblastoma treatments

$115,503
Edikan Ogunnaike · Univ Of North Carolina Chapel Hill · K99 · FY2023 · NS

HaemAPA: Characterizing alternative polyadenylation in human blood cells

$115,500
Zheng Xia · Oregon Health & Science University · R21 · FY2019 · HL

HaemAPA: Characterizing alternative polyadenylation in human blood cells

$115,500
Zheng Xia · Oregon Health & Science University · R21 · FY2020 · HL

Imaging Vasular Tumors caused by Loss of Notch Function

$115,360
Raphael Kopan · Washington University · P50 · FY2015 · CA

Functional Interaction of GBAS and SLC41A2 in Drosophila models for UDP_755

$115,123
Rong Grace Zhai · University Of Miami School Of Medicine · R21 · FY2019 · GM

Core--Protein Purification

$115,026
Pankaj Gupta · Virginia Commonwealth University · P01 · FY2009 · CA

"Research Supplement to Promote Diversity in Health-Related Research", as part of Moffitt PS-OC, "Cancer as a Complex adaptive System"

$114,706
Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2018 · CA

Cancer as a Complex Adaptive System

$114,507
Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2018 · CA

Dissecting spatiotemporal heterogeneity of glioblastoma evolution under therapy

$113,995
Simona Migliozzi · University Of Miami School Of Medicine · K99 · FY2025 · CA

HSP27: A modulator and therapeutic target of SPARC-induced glioma invasion.

$113,311
Sandra Ann Rempel · Henry Ford Health System · R01 · FY2013 · CA